<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Idiopathic giant cell <z:mp ids='MP_0001856'>myocarditis</z:mp> (GCM) and <z:e sem="disease" ids="C0392077" disease_type="Disease or Syndrome" abbrv="">cardiac sarcoidosis</z:e> (CS) are <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare disorders</z:e> that cause <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, often with <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> or <z:hpo ids='HP_0001678'>heart block</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infection</z:e>, autoimmune processes, and genetics have <z:hpo ids='HP_0000001'>all</z:hpo> been implicated in the pathogenesis of these diseases, but the etiology for both diseases is likely a complex multifactorial process </plain></SENT>
<SENT sid="2" pm="."><plain>Both GCM and CS are generally progressive despite treatment with standard <z:hpo ids='HP_0001635'>heart failure</z:hpo> and <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> therapies </plain></SENT>
<SENT sid="3" pm="."><plain>Making the diagnosis of GCM or CS on initial clinical presentation is possible in only a small percentage of patients, so myocardial tissue diagnosis is required </plain></SENT>
<SENT sid="4" pm="."><plain>The use of multiple noninvasive imaging modalities may aid in diagnosis and assessment of response to treatment </plain></SENT>
<SENT sid="5" pm="."><plain>Establishing the diagnosis of GCM or CS early is crucial, as tailored immunosuppressive treatment may significantly alter the clinical course of these patients </plain></SENT>
<SENT sid="6" pm="."><plain>The prognosis of patients with GCM is poor, while the prognosis for patients with CS varies according to degree of left ventricular dysfunction </plain></SENT>
</text></document>